Swiss National Bank
AGL icon

Swiss National Bank’s Agilon Health AGL Stock Holding History

Swiss National Bank’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,632
Closed -$609K – 2313
2025
Q3 		$609K Hold
23,632
– – ﹤0.01% 2278
2025
Q2 		$1.36M Sell
23,632
-480
-2% -$38.5K ﹤0.01% 1996
2025
Q1 		$2.61M Hold
24,112
– – ﹤0.01% 1612
2024
Q4 		$1.15M Hold
24,112
– – ﹤0.01% 2146
2024
Q3 		$2.37M Hold
24,112
– – ﹤0.01% 1771
2024
Q2 		$3.94M Hold
24,112
– – ﹤0.01% 1416
2024
Q1 		$3.68M Buy
24,112
+136
+0.6% +$22.6K ﹤0.01% 1494
2023
Q4 		$7.52M Sell
23,976
-2,720
-10% -$984K 0.01% 1044
2023
Q3 		$11.9M Buy
26,696
+256
+1% +$116K 0.01% 801
2023
Q2 		$11.5M Buy
26,440
+8,660
+49% +$4.87M 0.01% 836
2023
Q1 		$10.6M Sell
17,780
-2,064
-10% -$1.16M 0.01% 845
2022
Q4 		$8.01M Buy
19,844
+556
+3% +$261K 0.01% 1029
2022
Q3 		$11.3M Buy
19,288
+176
+0.9% +$105K 0.01% 824
2022
Q2 		$10.4M Buy
+19,112
New +$9.67M 0.01% 898

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Swiss National Bank's AGL Position: Q4 2025 in Review

Swiss National Bank sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 23,632 shares — an estimated $609K sold.

Swiss National Bank first reported a position in AGL in Q2 2022 and held it in 14 quarters. The position peaked at $11.9M in Q3 2023. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Swiss National Bank reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Swiss National Bank sold 23,632 Agilon Health shares in Q4 2025, an estimated $609K.
  • Swiss National Bank first reported a position in Agilon Health in Q2 2022 and held it in 14 quarters.
  • Swiss National Bank's Agilon Health position peaked at $11.9M in Q3 2023.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.